Hefei Hengxin Life Science and Technology Co., Ltd. Class A

Hefei Hengxin Life Science and Technology Co., Ltd. Class A

SSZSE:301501
23.50
CNY
+0.12
(+0.51%)
0.88EPS
30.68P/E
3.97BMarket Cap
May 04Next Earn

Total Valuation

CNY

As of September 30, 2026, Hefei Hengxin Life Science and Technology Co., Ltd. Class A carries a market capitalization of 3.97B, placing it among publicly traded companies globally. Its enterprise value stands at 3.87B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap3.97B
Enterprise Value3.87B

Important Dates

Hefei Hengxin Life Science and Technology Co., Ltd. Class A's next confirmed earnings release is scheduled for May 4, 2027.

Earnings Date5/4/2027

Share Statistics

As of September 30, 2026, Hefei Hengxin Life Science and Technology Co., Ltd. Class A has 147.90M shares outstanding.

Shares Outstanding147.90M

Valuation Ratios

As of September 30, 2026, Hefei Hengxin Life Science and Technology Co., Ltd. Class A trades at a trailing price-to-earnings ratio of 30.68. The price-to-sales ratio is 2.07, and the price-to-book ratio stands at 1.90.

PE Ratio30.68
PS Ratio2.07
PB Ratio1.90
P/TBV Ratio2.01

Enterprise Valuation

As of September 30, 2026, Hefei Hengxin Life Science and Technology Co., Ltd. Class A trades at an EV/EBITDA multiple of 23.63 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 2.02 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 23.63 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. These enterprise value multiples are built on an enterprise value of 3.87B versus a market cap of 3.97B, with the gap driven by net debt and cash on the balance sheet.

EV / Sales2.02
EV / EBITDA23.63
EV / EBIT23.63

Financial Position

As of September 30, 2026, Hefei Hengxin Life Science and Technology Co., Ltd. Class A maintains a current ratio of 1.94, meaning it holds 1.9x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 13.34, indicating elevated leverage, while an interest coverage ratio of 34.46 demonstrates strong ability to service its debt obligations.

Current Ratio1.94
Quick Ratio0.87
Debt / Equity13.34
Debt / EBITDA1.76
Interest Coverage34.46

Financial Efficiency

CNY

Over the twelve months ended September 30, 2026, Hefei Hengxin Life Science and Technology Co., Ltd. Class A posted a return on equity (ROE) of 6.32, showing how much profit the company earns on every dollar of shareholder capital. Return on invested capital (ROIC) comes in at 5.48 - the clearest signal of whether the business earns more on its capital than that capital costs, and the core measure of a durable competitive advantage. Return on assets (ROA) stands at 4.64, measuring how efficiently the asset base is converted into earnings. Return on capital employed (ROCE) is 5.59, useful for judging operating efficiency across full business cycles. The company generates approximately 740,634.22 in revenue per employee across its workforce of 2,586.00, a quick read on workforce productivity versus industry peers. Inventory turnover of 5.97 indicates how many times Hefei Hengxin Life Science and Technology Co., Ltd. Class A sells and replaces its inventory over a year, a key working capital efficiency ratio.

Return on Equity (ROE)6.32
Return on Assets (ROA)4.64
Return on Invested Capital (ROIC)5.48
Return on Capital Employed (ROCE)5.59
Revenue Per Employee740,634.22
Employee Count2,586.00
Inventory Turnover5.97

Taxes

CNY

Over the twelve months ended September 30, 2026, Hefei Hengxin Life Science and Technology Co., Ltd. Class A recorded 32.80M in income tax expense. That works out to an effective tax rate of 20.18, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 162.49M, leaving 129.27M in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

Income Tax32.80M
Effective Tax Rate20.18

Stock Price Statistics

CNY

As of the close on November 17, 2026, Hefei Hengxin Life Science and Technology Co., Ltd. Class A's stock has declined approximately 47.99% over the past 52 weeks. The 50-day moving average sits at 25.85, while the 200-day moving average is 31.74.

52-Week Price Change-47.99%
50-Day Moving Average25.85
200-Day Moving Average31.74

Income Statement

CNY

Over the twelve months ended September 30, 2026, Hefei Hengxin Life Science and Technology Co., Ltd. Class A generated 1.92B in revenue and converted that into 129.27M in net income, yielding earnings per share of 0.88. EBITDA reached 163.69M, while operating income came in at 170.39M.

Revenue1.92B
Gross Profit360.85M
Operating Income170.39M
Pretax Income162.49M
Net Income129.27M
EBITDA163.69M
EBIT163.69M
Earnings Per Share (EPS)0.88

Balance Sheet

CNY

As of September 30, 2026, Hefei Hengxin Life Science and Technology Co., Ltd. Class A holds 462.90M in cash and equivalents against 288.47M in total debt, resulting in a net debt position of -37.59M. Total book value stands at 2.09B, with working capital of 499.36M providing operational flexibility.

Cash & Cash Equivalents462.90M
Total Debt288.47M
Net Debt-37.59M
Equity (Book Value)2.09B
Book Value Per Share14.11
Working Capital499.36M

Cash Flow

CNY

These figures cover the twelve months ended September 30, 2026.

Capital Expenditures-436.05M

Margins

Over the twelve months ended September 30, 2026, Hefei Hengxin Life Science and Technology Co., Ltd. Class A posted a gross margin of 18.84, reflecting its pricing power and cost economics. The operating margin of 8.90 and net profit margin of 6.75 provide insight into operational efficiency.

Gross Margin18.84
Operating Margin8.90
Pretax Margin8.48
Profit Margin6.75
EBITDA Margin8.55

Dividends & Yields

CNY

Over the twelve months ended September 30, 2026, Hefei Hengxin Life Science and Technology Co., Ltd. Class A paid dividends of 0.38 per share. The dividend payout ratio of 42.90 indicates the proportion of earnings distributed to shareholders, a key gauge of how sustainable the dividend is and how much room remains for future dividend growth. Total shareholder yield is negative at -0.14, meaning Hefei Hengxin Life Science and Technology Co., Ltd. Class A raised more capital through share issuance and new debt than it returned via dividends and buybacks.

Dividend Per Share0.38
Payout Ratio42.90
Shareholder Yield-0.14

Stock Splits

Hefei Hengxin Life Science and Technology Co., Ltd. Class A's most recent stock split took place on June 6, 2025 with a 20:29 split ratio.

Last Split Date6/6/2025
Split Ratio20:29

Scores

As of September 30, 2026, Hefei Hengxin Life Science and Technology Co., Ltd. Class A has an Altman Z-Score of 5.05, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score5.05